Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on NASDAQ
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on NASDAQ
Today’s data is for companies listed on the NASDAQ.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| GOOG | Alphabet Inc | 2017 | 943.000000 | 1027.8180 | USD | 11 |
| GOOGL | Alphabet Inc | 2017 | 964.610000 | 1027.8180 | USD | 11 |
| AMZN | Amazon.com Inc | 2017 | 966.070000 | 1108.9000 | USD | 10 |
| PCLN | The Priceline Group Inc | 2017 | 1829.800000 | 1998.5710 | USD | 7 |
| CHTR | Charter Communications Inc | 2017 | 320.010000 | 377.2000 | USD | 5 |
| SHPG | Shire PLC | 2017 | 184.790000 | 235.4486 | USD | 3 |
| BIIB | Biogen Inc | 2017 | 257.640000 | 306.5000 | USD | 6 |
| EQIX | Equinix Inc | 2017 | 427.640000 | 489.0000 | USD | 3 |
| ALXN | Alexion Pharmaceuticals Inc | 2017 | 120.300000 | 160.0000 | USD | 3 |
| INCY | Incyte Corp | 2017 | 117.760000 | 148.6667 | USD | 3 |
| ORLY | O’Reilly Automotive Inc | 2017 | 254.910000 | 300.5000 | USD | 4 |
| ULTA | Ulta Beauty Inc | 2018 | 293.330000 | 321.5000 | USD | 4 |
| TSRO | Tesaro Inc | 2017 | 149.510000 | 185.0000 | USD | 2 |
| SBNY | Signature Bank | 2017 | 142.330000 | 178.0000 | USD | 1 |
| RGLD | Royal Gold Inc | 2018 | 78.550000 | 124.5468 | CAD | 2 |
| NBIX | Neurocrine Biosciences Inc | 2017 | 53.930000 | 88.3333 | USD | 3 |
| MEOH | Methanex Corp | 2017 | 44.000000 | 73.5345 | CAD | 7 |
| LANC | Lancaster Colony Corp | 2018 | 122.000000 | 160.0000 | USD | 1 |
| ICPT | Intercept Pharmaceuticals Inc | 2017 | 119.590000 | 165.2500 | USD | 4 |
| AGIO | Agios Pharmaceuticals Inc | 2017 | 53.400000 | 82.5000 | USD | 2 |
| MSTR | MicroStrategy Inc | 2017 | 187.660000 | 225.5000 | USD | 2 |
| STMP | Stamps.com Inc | 2017 | 118.300000 | 155.5000 | USD | 2 |
| SRPT | Sarepta Therapeutics Inc | 2017 | 35.330000 | 76.0000 | USD | 1 |
| UFPI | Universal Forest Products Inc | 2017 | 89.940000 | 123.0000 | USD | 1 |
| ATRA | Atara Biotherapeutics Inc | 2017 | 15.250000 | 47.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
PCLN:NAS Priceline Group
http://www.pricelinegroup.com
Priceline Group has 20500 employees and is headquartered in United States.
The Priceline Group Inc is a provider of online travel and travel related reservation and search services. The Company offer consumers accommodation reservations through its Booking.com, priceline.com and agoda.com brands.
ALXN:NAS Alexion Pharmaceuticals
http://www.alexionpharm.com
Alexion Pharmaceuticals has 3121 employees and is headquartered in United States.
Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.